Has NatWest overpaid for Evelyn or should have chosen Rathbones?

NatWest has agreed to buy wealth manager Evelyn Partners for £2.7bn, a deal that knocked NatWest shares down about 4% to 632.8p and values Evelyn at roughly 15x historic EBITDA (based on a £179m profit). NatWest is targeting £100m of annual cost savings that it says would reduce the effective multiple to just under 10x, and the acquisition will use ~130 basis points of capital with an expected IRR above the ~11% implied cost of equity from a buyback. Analysts flagged concerns over price, the achievability of revenue synergies and the lost IPO route, while noting the transaction highlights continued consolidation in the UK wealth sector and creates valuation comparators for listed peers such as Rathbones.

Analysis

Market structure: NatWest’s (NWG) Evelyn purchase accelerates consolidation in UK wealth management, advantaging scale players (Coutts, large private banks) and pressuring mid-cap listed managers’ liquidity and multiples. Paying ~15x historic EBITDA (10x after £100m synergies) consumes ~130bp capital and compresses NatWest’s near-term buyback capacity; investor reaction (-4% NWG) signals skepticism on achievable synergies and immediate ROE accretion versus buybacks. For listed peers (Rathbones/RATH, St. James’s Place/STJ) this is a mixed signal: potential re-rating if strategic buyers emerge, but downward pressure if markets mark to deal multiples and discount revenue-synergy hopes.

Risk assessment: Tail risks include failed integration leading to goodwill impairments (>£500m scenario), regulatory pushback on capital allocation (PRA scrutiny within 30–90 days), or macro shock widening UK bank spreads (gilts/Breakevens) that increases funding costs. Short-term (days–weeks) expect volatility in NWG equity and credit; medium-term (3–12 months) execution risk on £100m cost saves; long-term (2–4 years) value hinges on cross-sell success and AUM retention. Hidden dependencies: client attrition in transition, IT integration costs, and opportunity cost vs share buybacks (11% implied COE).

Trade implications: Tactical long in mid-cap UK wealth names exposed to M&A re-rating (RATH) and selective short/hedge on NWG is attractive: market has priced generous synergy assumptions. Options trades to express views: buy NWG 6–9 month puts (10–15% OTM) to hedge or speculate on further weakness; buy RATH 9–12 month call spreads to capture potential takeover re-rating while limiting premium.

Contrarian angle: Consensus assumes banks will deliver £100m+ synergies; history (Lloyds/Abbey) shows revenue synergies often fail. If synergies disappoint, NWG downside >15% and listed wealth managers could be re-rated lower, not higher — so asymmetric trade is buying cheap protection and small, conviction-long on RATH only after due diligence on AUM stickiness and fees.

Key Decisions for Investors

• Establish a 2–3% long position in Rathbones (RATH.L) over 3–9 months targeting +50% upside if market applies Evelyn’s AUM multiple; use a 20% stop-loss and scale in on intraday weakness below -10%.
• Implement a 1.5–2% short or hedge on NatWest (NWG.L) for 1–3 months targeting a 10–20% move; alternatively buy NWG 6–9 month puts 10–15% OTM (max premium = 0.5–1% notional) to limit downside risk while monitoring quarterly results for integration guidance.
• Buy a RATH 9–12 month call spread (bull call) to cap premium: long ATM-ish call, short 30–40% OTM call, position size 1–2% portfolio to capture M&A re-rating while limiting carry cost.
• Reduce cyclical bank overweight by 1–2% in favor of defensive professional-services/asset-manager exposure (RATH, STJ) and increase cash/short-dated gilts hedges if UK 10y gilt yield rises >50bp in 30 days (protecting duration-sensitive bank capital metrics).